Early clinical trial results suggest that a groundbreaking new antibiotic drug could be a “massive game changer” for some patients suffering from chronic lower back pain.

The FDA granted accelerated approval to atrasentan (Vanrafia) for the reduction of proteinuria in adults with primary ...

Once rampant in Philly's drug supply, xylazine is now on the decline after a statewide crackdown, experts tell Axios. Why it matters: The drug, known on the streets as "tranq," is being replaced by a ...